Chemoprevention of lung cancer

Soon daily practice?

Nico van Zandwijk, Ugo Pastorino

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The statistics on lung cancer survival remain disappointing and form a powerful argument to develop new methods to control this most deadly form of cancer in both men and women. Chemoprevention is one of these new approaches. While carcinogens from cigarette smoke form an essential link between nicotine addiction and lung cancer, several investigations confirm that dietary and genetically determined factors play an important role in modulating the individual susceptibility and are linked to the chemoprevention approach. In spite of a large abundance of positive preclinical observations, most experiences with potential chemopreventive agents, such as retinoids and antioxidants in individuals at risk for lung cancer have been so far negative. Moreover, β-carotene was associated with an increased lung cancer incidence in two large randomized studies, as a consequence of a negative interaction with smoking. On the other hand, recent progress in molecular biology has led to the discovery of specific approaches to chemoprevention and there considerable optimism regarding the potential of molecules and antibodies that target specific receptors or mutations. Epidermal growth factor receptor blocking agents, farnesyltransferase and cyclooxygenase inhibitors and 9-cis retinoic acid have been identified as promising candidates for studies in high risk populations. After more than 20 years of worldwide research, the prospects for effective lung cancer treatment are better than ever.

Original languageEnglish
Pages (from-to)91-98
Number of pages8
JournalExpert Review of Anticancer Therapy
Volume3
Issue number1
DOIs
Publication statusPublished - Feb 2003

Fingerprint

Chemoprevention
Lung Neoplasms
Farnesyltranstransferase
Cyclooxygenase Inhibitors
Retinoids
Carotenoids
Nicotine
Epidermal Growth Factor Receptor
Smoke
Tobacco Products
Carcinogens
Molecular Biology
Antioxidants
Smoking
Mutation
Survival
Antibodies
Incidence
Research
Population

Keywords

  • Antioxidants
  • B-carotene
  • Carcinogens
  • Chemoprevention
  • Cyclooxygenase inhibitors
  • Farnsyltransferase
  • Lung cancer
  • NSCLC
  • Retinods

ASJC Scopus subject areas

  • Pharmacology
  • Cancer Research

Cite this

Chemoprevention of lung cancer : Soon daily practice? / van Zandwijk, Nico; Pastorino, Ugo.

In: Expert Review of Anticancer Therapy, Vol. 3, No. 1, 02.2003, p. 91-98.

Research output: Contribution to journalArticle

@article{e4a06917dcc146c8a003365c094b322b,
title = "Chemoprevention of lung cancer: Soon daily practice?",
abstract = "The statistics on lung cancer survival remain disappointing and form a powerful argument to develop new methods to control this most deadly form of cancer in both men and women. Chemoprevention is one of these new approaches. While carcinogens from cigarette smoke form an essential link between nicotine addiction and lung cancer, several investigations confirm that dietary and genetically determined factors play an important role in modulating the individual susceptibility and are linked to the chemoprevention approach. In spite of a large abundance of positive preclinical observations, most experiences with potential chemopreventive agents, such as retinoids and antioxidants in individuals at risk for lung cancer have been so far negative. Moreover, β-carotene was associated with an increased lung cancer incidence in two large randomized studies, as a consequence of a negative interaction with smoking. On the other hand, recent progress in molecular biology has led to the discovery of specific approaches to chemoprevention and there considerable optimism regarding the potential of molecules and antibodies that target specific receptors or mutations. Epidermal growth factor receptor blocking agents, farnesyltransferase and cyclooxygenase inhibitors and 9-cis retinoic acid have been identified as promising candidates for studies in high risk populations. After more than 20 years of worldwide research, the prospects for effective lung cancer treatment are better than ever.",
keywords = "Antioxidants, B-carotene, Carcinogens, Chemoprevention, Cyclooxygenase inhibitors, Farnsyltransferase, Lung cancer, NSCLC, Retinods",
author = "{van Zandwijk}, Nico and Ugo Pastorino",
year = "2003",
month = "2",
doi = "10.1586/14787210.3.1.91",
language = "English",
volume = "3",
pages = "91--98",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - Chemoprevention of lung cancer

T2 - Soon daily practice?

AU - van Zandwijk, Nico

AU - Pastorino, Ugo

PY - 2003/2

Y1 - 2003/2

N2 - The statistics on lung cancer survival remain disappointing and form a powerful argument to develop new methods to control this most deadly form of cancer in both men and women. Chemoprevention is one of these new approaches. While carcinogens from cigarette smoke form an essential link between nicotine addiction and lung cancer, several investigations confirm that dietary and genetically determined factors play an important role in modulating the individual susceptibility and are linked to the chemoprevention approach. In spite of a large abundance of positive preclinical observations, most experiences with potential chemopreventive agents, such as retinoids and antioxidants in individuals at risk for lung cancer have been so far negative. Moreover, β-carotene was associated with an increased lung cancer incidence in two large randomized studies, as a consequence of a negative interaction with smoking. On the other hand, recent progress in molecular biology has led to the discovery of specific approaches to chemoprevention and there considerable optimism regarding the potential of molecules and antibodies that target specific receptors or mutations. Epidermal growth factor receptor blocking agents, farnesyltransferase and cyclooxygenase inhibitors and 9-cis retinoic acid have been identified as promising candidates for studies in high risk populations. After more than 20 years of worldwide research, the prospects for effective lung cancer treatment are better than ever.

AB - The statistics on lung cancer survival remain disappointing and form a powerful argument to develop new methods to control this most deadly form of cancer in both men and women. Chemoprevention is one of these new approaches. While carcinogens from cigarette smoke form an essential link between nicotine addiction and lung cancer, several investigations confirm that dietary and genetically determined factors play an important role in modulating the individual susceptibility and are linked to the chemoprevention approach. In spite of a large abundance of positive preclinical observations, most experiences with potential chemopreventive agents, such as retinoids and antioxidants in individuals at risk for lung cancer have been so far negative. Moreover, β-carotene was associated with an increased lung cancer incidence in two large randomized studies, as a consequence of a negative interaction with smoking. On the other hand, recent progress in molecular biology has led to the discovery of specific approaches to chemoprevention and there considerable optimism regarding the potential of molecules and antibodies that target specific receptors or mutations. Epidermal growth factor receptor blocking agents, farnesyltransferase and cyclooxygenase inhibitors and 9-cis retinoic acid have been identified as promising candidates for studies in high risk populations. After more than 20 years of worldwide research, the prospects for effective lung cancer treatment are better than ever.

KW - Antioxidants

KW - B-carotene

KW - Carcinogens

KW - Chemoprevention

KW - Cyclooxygenase inhibitors

KW - Farnsyltransferase

KW - Lung cancer

KW - NSCLC

KW - Retinods

UR - http://www.scopus.com/inward/record.url?scp=0037322487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037322487&partnerID=8YFLogxK

U2 - 10.1586/14787210.3.1.91

DO - 10.1586/14787210.3.1.91

M3 - Article

VL - 3

SP - 91

EP - 98

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 1

ER -